Prashant trained in family medicine, bioengineering, computer science, innovation management and design. He leads the training and program development activities the School of International Biodesign(SiB). At SiB Dr. Jha trains physicians, engineers, designers, researchers and entrepreneurs in the science and art of innovating low-cost, high-impact medical devices. He has played a key role in initiating medical technology innovation programs at QUT, Australia and Universities of Tokyo and Osaka in Japan.
In 2014 he co-founded the world’s first Medical Innovations journal – BMJ Innovations (innovations.bmj.com) and serves as its editor. The journal publishes innovations in medical devices, diagnostics, assistive technologies, mHealth and systems innovations.
Dr. Jha, with his team, has invented multiple medical devices in areas of pregnancy monitoring, wearables for hypertensives and diabetics, stress urinary incontinence and stroke. He serves as the product evangelist at Brün Health – which is working to commercialize some of these inventions.
About School of International Biodesign (SiB), India
SiB trains MedTech leaders from the disciplines of Medicine, Engineering, Design and Business. Its flagship training program, the one-year fellowship, has drawn students from India, Indonesia, Malaysia, Japan, Singapore, USA and Europe. Using its Define-Design-Deploy methodology for developing value driven medical technologies for global healthcare challenges, the school has developed over 50 medical technologies in the last ten years. The graduating fellows have launched over a dozen startups that have taken multiple medical technologies to patients globally. The innovations from the School have been granted patents in India, Europe, Japan and USA and have been approved by regulators like US FDA, Japan FDA, CE among others. The mission of the school is best described by the acronym G.A.N.D.H.I. ( Global Affordable Need Driven Health Innovations ).
BMJ Innovations – a joint initiative of the British Medical Journal group and AIIMS, it is the first peer-reviewed, international, general medical innovations journal. With readership and contributions now spanning Asia, Europe, Australia, Africa and North America it it running in its second year.